Get an overall health score across your five most important startup metrics — and a clear improvement priority list.
Your startup health score combines growth, retention, efficiency, sales effectiveness, and product engagement into a single number. No single metric tells the whole story — a company growing fast but burning excessively, or retaining customers but not growing, has identifiable weaknesses that this score surfaces.
Month-over-month ARR growth %
%
NRR — existing cohort revenue growth
%
Net burn ÷ net new ARR (lower is better)
Lifetime value divided by acquisition cost (3+ is good)
Growth tells investors the market exists and the product is gaining traction. Retention tells them the product creates durable value. Efficiency (burn multiple) tells them the capital is being deployed intelligently. LTV:CAC tells them the economics are sound. Churn tells them whether customers stay.
No single metric is sufficient. 200% YoY growth with 40% annual churn is a leaky bucket. Excellent NRR but flat growth signals a strong niche without expansion. The composite score reveals the true health of the business.
KPI Score Benchmarks
Score Range
Classification
Fundraising Outlook
Priority Action
Status
80–100
Exceptional
Strong series raise
Maintain and scale
60–79
Strong
Fundable
Fix weakest metric
40–59
Developing
Seed/bridge stage
Fix retention first
< 40
Early stage
Find PMF first
Retention + growth
Source: Composite benchmark from Bessemer, OpenView, and First Round Capital 2024–2025
Common Mistakes
⚠️
Optimising the score, not the business
These metrics are proxies for business health — not goals in themselves. Don't cut sales spend to improve burn multiple if it hurts growth. Optimise the business; the score should follow.
⚠️
Ignoring the weakest metric
Investors will find your weakest metric in diligence. A 90/100 score with churn at 8%/month won't survive a detailed diligence process. Fix weaknesses before fundraising, not after.
⚠️
Not tracking metrics consistently
These metrics should be tracked monthly, with a rolling 3-month average for growth metrics. Inconsistent definitions make benchmarking impossible and undermine credibility in investor conversations.
